Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)

Completed · Phase 2

Conditions studied: Aging

In brief

This study addresses a "lifespan approach to healthy development and aging" with direct relevance to humans by testing the anti-aging effects of acarbose in humans. It is a pilot study to: i) better estimate power for a larger trial, ii) establish the safety and potential beneficial effects of acarbose in non-diabetic elderly humans, and iii) determine whether the effects of acarbose on the microbiome likely play a role in its enhancement of longevity and/or healthy aging. These are essential initial steps for translating acarbose into an anti-aging human therapy.

Key facts

Study ID
NCT02865499
Run by
The University of Texas Health Science Center at San Antonio
People needed
8
Starts
2016-06-01
Expected to finish
2017-10-01
Last updated by the study team
2019-03-14

Who can join

Age: 70 and older, up to 95. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.